American Pharmacists Association Academy of Student Pharmacists

APhA2014 Annual Meeting & Exposition

2014 APhA-ASP REFERENCE COMMITTEE REPORT

The APhA-ASP Reference Committee met in closed session from 6:30pm – 7:45pm on Saturday, March 29, 2014.

The members of the 2014 APhA-ASP Reference Committee are as follows:

Chair: JT Fannin, 2013-2014 APhA-ASP Speaker of the House

Region 1: Jonathan Lee, University of Connecticut

Region 2: AeRee Choi, Wilkes University

Region 3: Will Beaty, East Tennessee State University

Region 4: Samantha Landolfa, U. of Illinois at Chicago

Region 5: Joshua Rose, The University of Iowa

Region 6: Puja Patel, St. Louis College of Pharmacy

Region 7: Sydney Root, University of Washington

Region 8: Nestle Jane Austero, Roseman University

2014 REFERENCE COMMITTEE RECOMMENDATIONS

The APhA-ASP Reference Committee considered the testimony presented during the APhA-ASP Open Hearing on Proposed Resolutions on the Report of the 2014 APhA-ASP Resolutions Committee.

2014.1 – Pharmacogenomics

1. APhA-ASP supports the utilization of evidence-based pharmacogenomic testing and services to enhance individualization of patient care and improve clinical outcomes.

The Reference Committee recommends to ADOPT Issue 2014.1.1 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

2. APhA-ASP promotes pharmacists as the primary member of the health care team responsible for pharmacogenomic services, including but not limited to, interpreting and applying test results, developing individualized medication treatment plans in collaboration with prescribers, and serving as a resource to prescribers, patients, and other members of the health care team.

The Reference Committee recommends to ADOPT Issue 2014.1.2 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

3. APhA-ASP supports continued research, development and implementation of clinical standards and guidelines regarding the use of pharmacogenomics to improve patient care.

The Reference Committee recommends to ADOPT Issue 2014.1.3 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

4. APhA-ASP supports ongoing vigilance by all stakeholders with access to pharmacogenomic information to maintain the confidentiality and ensure the appropriate use of the information.

The Reference Committee recommends to ADOPT Issue 2014.1.4 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

5. APhA-ASP encourages all schools and colleges of pharmacy to incorporate pharmacogenomics throughout the curriculum.

The Reference Committee recommends to ADOPT Issue 2014.1.5 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

6. APhA-ASP encourages the development of continuing education and training programs to support existing practitioner understanding of pharmacogenomics.

The Reference Committee recommends to ADOPT Issue 2014.1.6 of the Committee Report, and I so move.

2014.1 – Pharmacogenomics

7. APhA-ASP encourages all stakeholders, including but not limited to, employers, pharmacies, health-systems, and third party payers, to develop a compensation model for pharmacist-provided pharmacogenomic services that is both financially viable and in the best interest of patients.

The Reference Committee recommends to ADOPT Issue 2014.1.7 of the Committee Report, and I so move.

2014.2 – Dispensing and Administering Medications in Life-Threatening Situations

1. APhA-ASP supports pharmacists’ authority to dispense and administer medications, including but not limited to, naloxone, epinephrine auto-injectors, and albuterol inhalers, without a prescription in an emergency or life-threatening situation prior to the arrival of emergency medical services.

The Reference Committee recommends to ADOPT AS AMENDED Issue 2014.2.1 of the Committee Report, and I so move.

2014.2 – Dispensing and Administering Medications in Life-Threatening Situations

2. APhA-ASP supports protection from civil and criminal prosecution of medically trained personnel, including pharmacists, for actions taken in the best interest of the patient during an emergency or life-threatening situation.

The Reference Committee recommends to ADOPT AS AMENDED Issue 2014.2.2 of the Committee Report, and I so move.

2014.3 – Pharmacist-led Clinics

1. APhA-ASP supports the expansion of pharmacist-led clinics—in collaboration with other members of the health care team—that serve unmet health needs and facilitate increased access to patient care. These clinics may include, but not be limited to, anticoagulation, international travel, tobacco cessation, rural, underserved, and mobile health clinics.

The Reference Committee recommends to ADOPT Issue 2014.3.1 of the Committee Report, and I so move.

2014.3 – Pharmacist-led Clinics

2. APhA-ASP encourages all schools and colleges of pharmacy to incorporate entrepreneurship, business development, and practice management training in the curriculum to provide future pharmacists with the tools to operate and manage financially viable pharmacist-led clinics.

The Reference Committee recommends to ADOPT Issue 2014.3.2 of the Committee Report, and I so move.

2014.3 – Pharmacist-led Clinics

3. APhA-ASP encourages the expansion of residency, fellowship, and other postgraduate training programs within pharmacist-led clinics.

The Reference Committee recommends to ADOPT Issue 2014.3.3 of the Committee Report, and I so move.

2014.3 – Pharmacist-led Clinics

4. APhA-ASP encourages the development of grants or financial assistance programs to aid in the establishment and management of pharmacist-led clinics.

The Reference Committee recommends to ADOPT Issue 2014.3.4 of the Committee Report, and I so move.

2014 APhA-ASP NEW BUSINESS REVIEW COMMITTEE REPORT

The APhA-ASP New Business Review Committee did not meeting during the APhA2014 Annual Meeting & Exposition. One New Business Item was submitted and was withdrawn prior to the Open Hearing on New Business.